Skip to main content
TipRanks
Go Ultimate75% OFF

Diamedica Therapeutics (DMAC) Q2 2026 Earnings Report

573 Followers

DMAC Q2 2026 EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.20
Beat/Miss
Beat by +$0.01
One Year Ago EPS
-$0.18

DMAC Q2 2026 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
08/10/2026
Time
After Close
Conference Call
Monday, August 10, 2026
DMAC Upcoming Earnings

Diamedica Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DMAC Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DMAC Earnings History

DMAC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 23, 20272026 (Q4)-0.24--0.17――
Nov 12, 20262026 (Q3)-0.21-0.21-0.17-23.53% (-0.04)
Aug 10, 20262026 (Q2)-0.20-0.19-0.18-5.56% (-0.01)
May 06, 20262026 (Q1)-0.19-0.19-0.18-5.56% (-0.01)
Mar 30, 20262025 (Q4)-0.18-0.17-0.185.56% (+0.01)
Nov 12, 20252025 (Q3)-0.16-0.17-0.15-13.33% (-0.02)
Aug 12, 20252025 (Q2)-0.19-0.18-0.13-38.46% (-0.05)
May 13, 20252025 (Q1)-0.18-0.18-0.14-28.57% (-0.04)
Mar 17, 20252024 (Q4)-0.17-0.18-0.12-50.00% (-0.06)
Nov 13, 20242024 (Q3)-0.15-0.15-0.12-25.00% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed